Cargando…
Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review
Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low, mild to moderate COVID-19 may progress to severe or even critical stages in about one week. This poses a substantial burden on the health care system, and ultimately culminates in death or incapacitation and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297311/ https://www.ncbi.nlm.nih.gov/pubmed/34281149 http://dx.doi.org/10.3390/ijerph18137212 |